Special Issues

Special Issue Title: Immunology in gynecological cancer

· Print Special Issue Flyer

· Deadline for manuscript submissions: 30 May 2021


Special Issue Editor

Guest Editor



Dr. Eddie Fernando Candido Murta

Department of Gynecology and Obstetrics/IPON (Research Institute of Oncology), Federal University of Triangulo Mineiro (UFTM), Uberaba, MG.

Interests: Pathophysiology, Immunology and Immunotherapy (Vaccine of Dendritic Cells) Gynecologic Cancer, breast and other sites



Dr. Rosekeila Simõs Nomelini

Department of Gynecology and Obstetrics/IPON (Research Institute of Oncology), Federal University of Triangulo Mineiro (UFTM), Uberaba, MG

Interests: Ovarian cancer, uterine cervical cancer, breast cancer, cancer immunology



Dr. Millena Prata Jammal

Department of Gynecology and Obstetrics/IPON (Research Institute of Oncology), Federal University of Triangulo Mineiro (UFTM), Uberaba, MG

Interests: Ovarian cancer



Dr. Agrimaldo Martins Filho

Research Institute of Oncology (IPON)/Department of Gynecology and Obstetrics, Federal University of Triangulo Mineiro, Uberaba, Brazil

Interests: Ovarian cancer



Dr. Cid Almeida de Lima

Research Institute of Oncology (IPON)/Department of Gynecology and Obstetrics, Federal University of Triangulo Mineiro, Uberaba, Brazil

Interests: Ovarian Cancer, Gynecologic Cancer



Special Issue Information

Dear Colleagues,


The development of cancer may indicate a failure in the immune response through tumor escape mechanisms. The possibility of intervening and intensifying the action of the immune system to produce a beneficial anti-tumor response remains an area of intense research. Tumor cells exhibit a variety of escape mechanisms from immunodetection, leading to an ineffective immune response. In gynecological cancer, several cytokines and cells of the immune system can be used as potential markers, both for the diagnosis and for the prognosis of the disease. The profile of the immune response, whose differentiation and proliferation occurs in the production of certain cytokines, is capable of contributing to the induction of apoptosis, tumor control and regression. Several inflammatory mediators are induced by inflammatory and tumor cells and participate in the formation of cancer, acting as growth or angiogenic factors. One of the escape mechanisms that favors the maintenance of cancer is the triggering of an imbalance in the T helper 1 and T helper 2 response.

The tumor environment in which gynecological cancer develops has been described as a large site rich in pro-inflammatory cytokines and chemokines. Several of these cytokines are produced by the tumor itself, which in addition to stimulating the growth of tumor cells, are also responsible for creating a specific microenvironment that can promote cell proliferation and tumor growth, directly affecting the severity of inflammation.

Another important effector of the immune response to tumors is the peritumoral stroma. This stroma is composed of non-malignant tumor cells, such as cancer-associated fibroblast, mesenchymal cells, innate and adaptive immune cells, vasculature with endothelial cells and pericytes, in addition to an extracellular matrix consisting of structural proteins (collagen and elastin), specialized proteins (fibrillin, fibronectin and elastin) and proteoglycans.

Thus, the immune system plays a complex role in gynecological cancer and can, in different contexts, promote or inhibit tumor growth. The action of the immune system can be different in each gynecological tumor environment: systemic (study of the immune response in the serum of women with cancer), local (study of the tumor microenvironment and peritumoral stroma) and also in the sites around tumors (study of the response immune in the peritoneal fluid). The study of immunology in gynecological cancer is rich and may lead to the discovery of new diagnostic and prognostic markers. Consequently, new therapeutic targets will emerge with these researches, and improve the survival of gynecological cancer in the future.


Prof. Dr. Eddie Fernando Candido Murta

Guest Editor

 

Manuscript Submission Information

Manuscripts should be submitted online at https://ejgo.imrpress.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access quarterly journal published by IMR Press.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is $1250. We normally offer a discount greater than 30% (APC: $850) to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.


Keywords
Gynecological cancer, immunology, tumor microenvironment, cytokines, peritumoral stroma, immune response



Share This Special Issue

     




Planned Papers

Type: Original Research
Title: Pegylated-Interferon-alpha treatment modifying T cell cytokine profile in tumor microenvironment of patients with Cervical intraepithelial neoplasia
Authors: Dr. Eddie Fernando Candido Murtar


Type: Review
Title: Ovarian cancer immunology
Authors: Dr. Eddie Murta


Title: Mast cells and M2 macrophages in ovarian cancer
Authors: Ananda Domingues Lopes; Millena Prata Jammal; Renata Margarida Etchebehere; Eddie Fernando Candido Murta; Rosekeila Simões Nomelini


Title: Association of cancer-associated fibroblasts and survival in malignant ovarian neoplasms
Authors: Ana Carolline da Silva; Millena Prata Jammal; Renata Margarida Etchebehere; Eddie Fernando Candido Murta; Rosekeila Simões Nomelini


Title: Stromal CD56 immunostaining in ovarian malignancies
Authors: Cid Almeida de Lima; Millena Prata Jammal; Renata Margarida Etchebehere; Eddie Fernando Candido Murta; Rosekeila Simões Nomelini


Title: Evaluation of cytokine immunostaining in ovarian neoplasms and endometriomas
Authors: Paula Carolina Arvelos Crispim; Millena Prata Jammal; Renata Margarida Etchebehere; Eddie Fernando Candido Murta; Rosekeila Simões Nomelini


Title: Immune response in cervical intraepithelial neoplasms
Authors: Priscila Thaís Silva Mantoani; Daniela Rodrigues Siqueira; Millena Prata Jammal; Eddie Fernando Candido Murta; Rosekeila Simões Nomelini



Please wait a minute...
For Selected: Toggle Thumbnails

Current Issue

  • Volume 42, Issue 2